I think the bottom line is: the drug sucks for Covid. They hitched their wagon to this manna that fell from the sky. The principal players already cashed out some dough, and now they are dragging it along to try and keep it relevant (and to have funding) for the HIV and cancer trials.
This is an old drug (much like all these other therapeutic Covid drugs that we all know about and are invested in. They all just have different levels of deception.
The only question that remains is how long any of us are willing to stand atop the deck of cards these drugs are built on to make money,
For me, I’m ready to take so e losses and cash in on some minor profits to move on. There are way better money makers out there in the market.